Home
>
National Drug Code (NDC)
>
Daypro
Daypro - 0025-1381-51 - (OXAPROZIN)
Drug Information of Daypro
| Product NDC: | 0025-1381 |
| Proprietary Name: | Daypro |
| Non Proprietary Name: | OXAPROZIN |
| Active Ingredient(s): | 600 mg/1 & nbsp; OXAPROZIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Daypro
| Product NDC: | 0025-1381 |
| Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018841 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19921029 |
Package Information of Daypro
| Package NDC: | 0025-1381-51 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0025-1381-51) |
NDC Information of Daypro
| NDC Code | 0025-1381-51 |
| Proprietary Name | Daypro |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0025-1381-51) |
| Product NDC | 0025-1381 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | OXAPROZIN |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19921029 |
| Marketing Category Name | NDA |
| Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
| Substance Name | OXAPROZIN |
| Strength Number | 600 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
